Callan Family Office LLC Takes Position in Revvity Inc. $RVTY

Callan Family Office LLC purchased a new position in shares of Revvity Inc. (NYSE:RVTY) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 4,216 shares of the company’s stock, valued at approximately $469,000.

A number of other hedge funds also recently modified their holdings of RVTY. EdgePoint Investment Group Inc. grew its holdings in Revvity by 3.1% during the first quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company’s stock valued at $771,044,000 after purchasing an additional 265,204 shares during the period. Price T Rowe Associates Inc. MD raised its stake in shares of Revvity by 5.3% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,606,637 shares of the company’s stock valued at $832,693,000 after buying an additional 434,570 shares during the period. Janus Henderson Group PLC lifted its position in shares of Revvity by 2.3% during the 1st quarter. Janus Henderson Group PLC now owns 8,348,127 shares of the company’s stock valued at $731,386,000 after buying an additional 186,956 shares during the last quarter. BlackRock Inc. purchased a new position in shares of Revvity during the 2nd quarter valued at $852,070,000. Finally, Dimensional Fund Advisors LP grew its stake in shares of Revvity by 11.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,917,953 shares of the company’s stock worth $255,623,000 after acquiring an additional 305,837 shares during the period. Institutional investors own 86.65% of the company’s stock.

Analyst Upgrades and Downgrades

RVTY has been the topic of a number of research reports. Barclays boosted their price objective on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Wolfe Research began coverage on shares of Revvity in a research report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Sanford C. Bernstein started coverage on shares of Revvity in a research note on Friday, June 26th. They issued a “market perform” rating and a $115.00 target price for the company. TD Cowen reissued a “buy” rating on shares of Revvity in a research report on Wednesday, July 15th. Finally, Wall Street Zen cut shares of Revvity from a “buy” rating to a “hold” rating in a research note on Sunday, August 16th. Three equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. According to data from MarketBeat.com, Revvity has a consensus rating of “Hold” and an average target price of $108.36.

Revvity Stock Performance

NYSE:RVTY opened at $126.31 on Thursday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80. Revvity Inc. has a 52-week low of $81.22 and a 52-week high of $126.90. The firm has a market cap of $14.09 billion, a price-to-earnings ratio of 60.15, a PEG ratio of 2.27 and a beta of 1.07. The business’s fifty day moving average is $112.94 and its 200 day moving average is $100.82.

Revvity (NYSE:RVTY) last issued its earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, topping the consensus estimate of $1.21 by $0.20. The business had revenue of $729.69 million during the quarter, compared to the consensus estimate of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The firm’s revenue was down 1.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Research analysts predict that Revvity Inc. will post 5.36 EPS for the current year.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be issued a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. Revvity’s dividend payout ratio is presently 13.33%.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.